Alzheimer’s Disease/Dementia News

Alzheimer’s disease remains a significant public health challenge, with as many as 5.8 million Americans having had the disease in 2020, according to estimates in a study published in Alzheimer’s & Dementia.

Investigators should increase racial and geographic diversity and in-depth biomarker studies in dementia research to be more representative of routine practice to improve diagnosis and development of treatment for dementia.

In conjunction with World Alzheimer’s Day, Healio Psychiatry has compiled a list of articles covering recent research developments related to Alzheimer’s disease.

Social support in the form of listening is linked to improved cognitive resilience, according to findings published in JAMA Neurology.

NIH’s National Institute on Aging announced a $55.6 million grant for Alzheimer’s disease research conducted by the University of Washington, Kaiser Permanente Washington and the University of California San Diego.

NIH’s National Institute on Aging announced $14.8 million in funding across 5 years for institutions in North Carolina and Texas that will join a network of research centers for Alzheimer’s disease and related dementias.

Results of a cross-sectional study published in JAMA Neurology found that sleep durations outside of a normal range worsened amyloid beta burden and cognition, underlining the importance of sleep in older adults.

Black women had higher rates of Alzheimer’s disease and environmental exposure to fine particulate matter than white women, according to a prospective, population-based study in Journals of Gerontology: Series A.

Increased expression of various X chromosome genes had different impacts on tau burden and cognition in men and women with and without Alzheimer’s disease, according to a study in JAMA Neurology.

Patients with dementia-related psychosis self-reported severe symptoms that were not reduced by current treatments, according to findings published in Clinical Gerontologist.